Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 1143-38-0
Drug Levels and Effects
Summary of Use during Lactation
Topical anthralin has not been studied during breastfeeding. Anthralin has suspected mutagenic properties, so it should only be used if the potential benefit to the mother justifies potential risk to the infant.[1] If anthralin is used, ensure that the infant's skin does not come into direct contact with the areas of maternal skin that have been treated and the infant does not ingest the product from the mother's skin.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol. 2019;5:141–150. [PMC free article: PMC6637092] [PubMed: 31360745]
Substance Identification
Substance Name
Anthralin
CAS Registry Number
1143-38-0
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PMCPubMed Central citations
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Hydroquinone.[Drugs and Lactation Database (...]Review Hydroquinone.. Drugs and Lactation Database (LactMed®). 2006
- Syntheses of Anthracenones. 2. Preparation of 1,8-Dimethoxy- (Dimethylanthralin) and 4,5-Dihydroxy-9(10H)-anthracenone (Isoanthralin): A Revision.[J Org Chem. 1996]Syntheses of Anthracenones. 2. Preparation of 1,8-Dimethoxy- (Dimethylanthralin) and 4,5-Dihydroxy-9(10H)-anthracenone (Isoanthralin): A Revision.Prinz H, Burgemeister T, Wiegrebe W, Müller K. J Org Chem. 1996 Apr 19; 61(8):2857-2860.
- Syntheses of Anthracenones. 3. Revised Preparative Route to 10-Benzoyl-1,8-dihydroxy-9(10H)-anthracenones.[J Org Chem. 1996]Syntheses of Anthracenones. 3. Revised Preparative Route to 10-Benzoyl-1,8-dihydroxy-9(10H)-anthracenones.Prinz H, Wiegrebe W, Müller K. J Org Chem. 1996 Apr 19; 61(8):2861-2864.
- Inhibition of soybean lipoxygenase-1 by 10-butyryl substituted 1,8-dihydroxy-9-anthrone (butantrone).[Med Biol. 1986]Inhibition of soybean lipoxygenase-1 by 10-butyryl substituted 1,8-dihydroxy-9-anthrone (butantrone).Laakso S, Römer L, Mustakallio KK. Med Biol. 1986; 64(1):43-5.
- Review Tazarotene.[Drugs and Lactation Database (...]Review Tazarotene.. Drugs and Lactation Database (LactMed®). 2006
- Anthralin - Drugs and Lactation Database (LactMed®)Anthralin - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...